Brief: Implanet receives FDA clearance to market new Jazz Passer
Sept 12 (Reuters) - IMPLANET SA ALIMP.PA :
* ANNOUNCES THAT IT HAS RECEIVED FDA CLEARANCE TO MARKET
NEW JAZZ PASSER.
Source text for Eikon: ID:nBw7K54dYa
Further company coverage: ALIMP.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Implanet SA
See all newsFrench orthopedic implants maker Implanet's nine-month revenue jumps, partly on strong US momentum
French and Benelux stocks-Factors to watch on September 16
France's IMPLANET H1 revenue rises on medical equipment strength, US growth
Brief: IMPLANET H1 Revenue EUR 7.1 Million
France's IMPLANET H1 revenue rises on spine implants strength, US growth